“Some times I awaken and will’t feel how far we’ve arrive,” reported Dr. Doblin, 67, who now oversees the Multidisciplinary Association for Psychedelic Research, a multimillion dollar analysis and advocacy empire that employs one hundred thirty neuroscientists, pharmacologists and regulatory specialists Operating to lay the groundwork for t